HomeOTLK • NASDAQ
add
Outlook Therapeutics Inc
Previous close
$1.24
Day range
$1.20 - $1.39
Year range
$0.87 - $9.29
Market cap
45.02M USD
Avg Volume
428.14K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 11.95M | 106.20% |
Net income | 17.38M | 255.46% |
Net profit margin | — | — |
Earnings per share | -0.89 | -14.40% |
EBITDA | -21.58M | -109.60% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 5.70M | -44.94% |
Total assets | 17.01M | -21.58% |
Total liabilities | 67.30M | 46.21% |
Total equity | -50.29M | — |
Shares outstanding | 32.02M | — |
Price to book | -0.61 | — |
Return on assets | -235.73% | — |
Return on capital | 172.58% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | 17.38M | 255.46% |
Cash from operations | -10.97M | 15.84% |
Cash from investing | — | — |
Cash from financing | 1.74M | 54,839.96% |
Net change in cash | -9.22M | 29.23% |
Free cash flow | -2.90M | 68.97% |
About
Founded
2010
Website
Employees
23
